Ladenburg Thalmann Financial Services’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-58
Closed 5058
2016
Q3
$0 Hold
58
﹤0.01% 4973
2016
Q2
$0 Hold
58
﹤0.01% 4951
2016
Q1
$0 Hold
58
﹤0.01% 4936
2015
Q4
$0 Hold
58
﹤0.01% 4887
2015
Q3
$0 Hold
58
﹤0.01% 4852
2015
Q2
$1K Hold
58
﹤0.01% 4593
2015
Q1
$1K Hold
58
﹤0.01% 4512
2014
Q4
$1K Hold
58
﹤0.01% 4293
2014
Q3
$1K Hold
58
﹤0.01% 3863
2014
Q2
$1K Sell
58
-300
-84% -$3.24K ﹤0.01% 3834
2014
Q1
$4K Buy
358
+58
+19% +$687 ﹤0.01% 3377
2013
Q4
$4K Hold
300
﹤0.01% 3363
2013
Q3
$3K Hold
300
﹤0.01% 3390
2013
Q2
$3K Buy
+300
New +$2.68K ﹤0.01% 3264

Other funds holding ELOS

Ladenburg Thalmann Financial Services's ELOS Position: Q4 2016 in Review

Ladenburg Thalmann Financial Services sold out of Syneron Medical Ltd (ELOS) in Q4 2016, closing a stake of 58 shares.

Ladenburg Thalmann Financial Services first reported a position in ELOS in Q2 2013 and held it in 14 quarters. The position peaked at $4K in Q1 2014. 80 funds tracked by Wall St. Rank hold ELOS as of Q4 2016.

  • Ladenburg Thalmann Financial Services reported no remaining Syneron Medical Ltd position as of Q4 2016 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 58 Syneron Medical Ltd shares in Q4 2016.
  • Ladenburg Thalmann Financial Services first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 14 quarters.
  • Ladenburg Thalmann Financial Services's Syneron Medical Ltd position peaked at $4K in Q1 2014.
  • 80 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2016, filed 14 Feb 2017.